Performance
Medical Device Directive |
93/42/EEC |
Technical details
Input voltage |
100-240 V |
Power supply input frequency |
50-60 Hz |
Power
Power consumption (typical) |
15 W |
AC input voltage |
100-240 V |
Design
Safety |
CE 0344 Certified, Medical device class: IIa, UV-free: No UV or near UV radiation, Optical output classification: Risk Group 1 (EN 60601-2-57) |
Country of origin |
Netherlands |
Additionally
Colour of product |
White |
AC adapter bundled |
Y |
LED, USB, AC/DC, 100 - 240 V, 15 W, 50 - 60 Hz, 70 x 30 x 95 mm, 169 g
Gentle therapy to treat plaque psoriasis at home
The first UV-free blue LED-light treatment device
Choose when and where to have your treatment with the wearable medical device,
Philips BlueControl. Blue LED light is proven to significantly improve psoriasis plaque
symptoms. Experience this gentle UV-free therapy in your own home.
First blue light therapy to treat plaque psoriasis
- Innovative blue LED light treatment device
Gentle UV-free therapy without chemicals
- LEDs without UV-radiation
- No active ingredients or chemical substances are used
Convenient, easy-to-use, wearable medical device
- It's your choice when and where to have your treatment
- Easy to conduct treatment leading to high compliance
Proven significant improvement of plaque symptoms
- Blue light controls the processes that cause psoriasis plaques
- Significant improvement of plaque symptoms shown in studies
Innovative blue LED light
Philips BlueControl is the world's first wearable phototherapy for mild to moderate plaque psoriasis. It combines all the beneficial effects of blue LED light for the treatment of psoriasis plaques in one small battery-driven device. Thanks to the innovative design of the medical device, patients are now able to treat their plaques at home with gentle, UV-free phototherapy.
Gentle UV-free light therapy
The 40 integrated blue LEDs in Philips BlueControl are long-lasting and safe sources of light for your skin. The LED settings have been optimised for the treatment of plaque psoriasis through in-depth research carried out across several years. Blue LED light belongs to the visible light range and is
therefore free of the risks of ultraviolet (UV) radiation.
Therapy without chemicals
Studies confirm that blue LED light, as used in Philips BlueControl, is not toxic for the skin. The blue light treatment induces natural processes in your skin helping to alleviate plaque symptoms. The therapy is gentle as it does not make use of any chemical substances.
Convenient, at home therapy
Be in control of your therapy with Philips BlueControl. You can choose where and when to treat your plaques with the cordless device. An accompanying textile strap allows Philips BlueControl to be worn comfortably on the limbs. The strap is easily adjustable and offers a secure fit, so you stay mobile during treatment and can engage in light activities.
Fits your daily life
Treat yourself in your own home with a very user-friendly wearable device. Simply attach the device to your arm or leg with the textile strap, press the button and continue your daily routine. At the end of the treatment the device switches off automatically. You don't need to think about it. Experience how easy it is to integrate the therapy with Philips BlueControl into your daily life in order to achieve great results.
Induces natural processes
Blue light induces natural processes in your skin leading to the improvement of your plaques. The irradiation with blue light is shown to reduce the accelerated production of skin cells associated with plaque psoriasis, helping skin to renew properly. The anti- inflammatory properties of blue light control unregulated inflammation and can alleviate the symptoms of affected skin.
Clinically proven therapy
The positive effects of blue LED light on plaque symptoms (redness, scaling and thickness) were confirmed in clinical trials. Over 12 weeks of treatment the plaque symptoms improved for the patients participating in the clinical study. For some patients the blue light even cleared their treated plaque completely. Patients confirmed that the therapy is very easy to use, leading to an astonishing treatment compliance of 98%.